Alan Adkins

Title: Innovations by Alan Adkins in Cardiac Treatment

Introduction

Alan Adkins is a notable inventor based in Angleton, Texas, who has made significant contributions to the field of medical technology. He holds 2 patents that focus on enhancing cardiac health, particularly for patients suffering from heart failure. His work is instrumental in developing methods that improve the quality of life for individuals with serious health conditions.

Latest Patents

One of Alan Adkins' latest patents is a method to enhance cardiac capillary growth in heart failure patients. This innovative approach involves electrically stimulating the patient's vagus nerve using an implanted neurostimulator. The stimulation is carefully modulated to achieve a target heart rate that remains stable, especially during rest. Additionally, an activity sensor adjusts the stimulation frequency based on the patient's physical activity, ensuring optimal heart function during various levels of exertion.

Another significant patent by Adkins focuses on activation techniques for implantable medical devices. This invention improves the functionality of neurostimulators designed to treat disorders by modulating the electrical activity of specific nerves. The neurostimulator can generate programmable electrical waveforms and is responsive to both manual and automatic signals, allowing for precise control over the treatment process.

Career Highlights

Alan Adkins is associated with Cyberonics, Inc., a company known for its advancements in neurostimulation technology. His work at Cyberonics has positioned him as a key player in the development of innovative medical devices that address critical health issues.

Collaborations

Throughout his career, Adkins has collaborated with notable colleagues, including Reese S Terry, Jr. and Burke T Barrett. These partnerships have fostered an environment of innovation and have contributed to the successful development of his patented technologies.

Conclusion

Alan Adkins is a pioneering inventor whose work in cardiac treatment through neurostimulation has the potential to transform patient care. His patents reflect a commitment to improving health outcomes for individuals with heart failure.